Flexible Work
AARP Skills Builder
Flexible Work
ON-DEMAND WEBINARS
Drug Prices
Social Security
Medicare & Medicaid
Caregiving
LONG-TERM CARE
State Guides
Prepare to Care Guides
End of Life
Home Technology
Get Happier
POSSIBILITIES OF AI
Relationships
Home Health
Leaving AARP.org Website
You are now leaving AARP.org and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.
BrandAmp by AARP provides the opportunity for our highly vetted marketing partners to share their expert knowledge, insights and storytelling with loyal and engaged readers like you. Each piece of paid content is created in collaboration with the disclosed advertiser and AARP Media Sales’ content development team.
BrandAmp by AARP content is designed to uphold AARP standards of excellence and inspire conversation. Only advertisers who have gone through the strictest reviews are cleared to bring their message directly to members using all of AARP media properties (AARP.org, social media, email newsletters and our print publications). Our pledge to members is work with brands whose products and services are of value to the 50+ audience; and are committed to the type of compelling, informative, entertaining and useful content members are accustomed to seeing within AARP media properties.
You are now leaving AARP.org and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.
The Food and Drug Administration warned consumers about the potential risk of eye infections associated with three brands of “copycat” eye drops— products that closely resemble major brands.
South Moon, Rebright and FivFivGo eye drops were cited for being easily mistaken for Bausch + Lomb’s Lumify brand eye drops, used to treat redness.
These copycat drugs are unapproved for sale in the U.S. and are marketed to treat eye conditions such as glaucoma, which would typically require a prescription drug or surgery.
Testing of South Moon and Rebright eye drops purchased online found that the products were contaminated with Burkholderia cepacia complex, a bacteria group that could lead to antibiotic-resistant infection. The eye drops also lacked brimonidine tartrate, the active ingredient in Lumify.
Although Rebright tested negative for contamination, the FDA is still advising consumers not to use the product.
It is unclear where the products are from, the FDA said. However, South Moon is labeled as made by Shantou Cross-border Premium Products E-Commerce Co. Ltd. in China.
There have been no reports of negative reactions to the specific products, but the FDA said it is aware of reports related to “possibly fake Lumify” eye drops such as product quality concerns, eye irritation, pain and infection.
The FDA recommends that consumers buy eye products only from reputable retailers such as state-licensed pharmacies, and not online retailers selling products with false claims.
Anyone with symptoms of an eye infection should seek medical care immediately.
According to the Centers for Disease Control and Prevention, signs of an eye infection include:
More on Eye Health
Should You Get Your Eyes Dilated?
Doctors can spot hundreds of diseases in an examElton John Has Lost His Eyesight
See 6 eye symptoms you shouldn't ignore
Tips for Treating Dry Eyes: Find Relief
Find relief from the pain, burning and redness, and get your tears back